KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $59,786,000 | +592.9% | 332,492 | +299.5% | 0.02% | +533.3% |
| Q2 2017 | $8,628,000 | +126.0% | 83,230 | +71.1% | 0.00% | +200.0% |
| Q1 2017 | $3,818,000 | +28.1% | 48,649 | -26.8% | 0.00% | 0.0% |
| Q4 2016 | $2,981,000 | +92.8% | 66,481 | +140.2% | 0.00% | 0.0% |
| Q3 2016 | $1,546,000 | +7.8% | 27,672 | -3.5% | 0.00% | 0.0% |
| Q2 2016 | $1,434,000 | +6.9% | 28,670 | -1.8% | 0.00% | 0.0% |
| Q1 2016 | $1,341,000 | -11.8% | 29,206 | +18.4% | 0.00% | 0.0% |
| Q4 2015 | $1,521,000 | -5.3% | 24,673 | -14.5% | 0.00% | 0.0% |
| Q3 2015 | $1,606,000 | +11.8% | 28,841 | +22.4% | 0.00% | 0.0% |
| Q2 2015 | $1,437,000 | -26.2% | 23,560 | -30.1% | 0.00% | – |
| Q1 2015 | $1,946,000 | +482.6% | 33,716 | +481.3% | 0.00% | – |
| Q4 2014 | $334,000 | +80.5% | 5,800 | -10.8% | 0.00% | – |
| Q3 2014 | $185,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|